TORONTO, Ontario, Feb. 26, 2018 /Weed Wire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE), is pleased to announce that it has completed a $3,000,000 strategic equity investment (the “Investment”) in BlissCo Cannabis Corp. (“BlissCo”).
Tag Archives: TSXV
Supreme Secures Supply Agreement with Namaste
TORONTO, Ontario, Jan. 25, 2018 /Weed Wire/ – The Supreme Cannabis Company, Inc. (the “Company” or “Supreme”) (TSXV:FIRE), is pleased to announce that its wholly-owned subsidiary, 8528934 Canada Ltd. (“7ACRES”), has entered into a Definitive Supply Agreement (the “Agreement”) with Cannmart, Inc. (“Cannmart”) a wholly-owned subsidiary of Namaste Technologies Inc.
Fourth Company Named as New Brunswick Recreational Cannabis Supplier
With the Picture Province estimating that recreational legalization will create hundreds of new jobs and generate up to $150 million annually in recreational sales, the province has named the fourth New Brunswick recreational cannabis supplier.
Canadian Cannabis Company Scores Supply Deal With Eighth Province
On Jan. 16, 2018, Canadian cannabis company Canopy Growth Corporation (TSX: WEED) announced its arrangement to provide marijuana to the province of Prince Edward Island.
Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants
VICTORIA, British Columbia, Dec. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common share purchase warrants (“Warrants”) issued by the Company on February 10, 2017.
Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019
TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that is has changed its name to “The Supreme Cannabis Company, Inc.” effective today. The name change was approved by the shareholders of the Company at the annual general and special meeting of shareholders held earlier today.
Supreme Purchases Adjacent Land for Ultra-Premium Cannabis Facility
TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme or the “Company”) (TSXV:FIRE) is pleased to announce the purchase of an approximately six acre property adjacent to the 7ACRES facility in Kincardine, Ontario.
Northern Vine Labs Expands Dealer’s License with Health Canada
VICTORIA, British Columbia, Dec. 15, 2017 /Weed Wire/ — Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE: ATT; OTC: ATTBF), today announced that Health Canada has approved an amendment to the Company’s dealer’s license.
Emerald Health Announces No Material Change
VICTORIA, British Columbia, Dec. 13, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.
Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.
VICTORIA, British Columbia, Nov. 29, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”).
Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fouth Facility
VICTORIA, British Columbia, Nov. 28, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) announced today that its licensed producer application (submitted through its subsidiary, Emerald Health Botanicals) for its new Richmond, BC greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (“OMC”).
Supreme Signs High-Quality Flower Supply LOI Agreement with ABLE BC.
TORONTO, Ontario, Nov. 24, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce it has entered into a Letter of Intent (“LOI”) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing BC’s private liquor industry.
Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine
VICTORIA, British Columbia, Nov. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. (“Northern Vine”) to acquire 53% of the company and appoint three of its four directors.
Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance
VICTORIA, British Columbia, Nov. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) today announced the appointment of Robert C. Hill, CPA, CA, as the Company’s Chief Financial Officer and the promotion of Cheryl L. Evans, CPA, CA, to Vice President Finance.
This Is the Third Company Signed on to Supply New Brunswick Marijuana
While New Brunswick marijuana was slated to be supplied by two public companies, the province has added one more licensed producer to the mix.
Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility
RICHMOND, British Columbia, Nov. 15, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (”OMC”).
Supreme Pharmaceuticals Closes $40.25 Million Bought Deal Private Placement of Convertible Debenture Units
TORONTO, Ontario, Nov. 14, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce the closing of its previously announced bought deal private placement of 40,250 convertible debenture units (the “Convertible Debenture Units”), including the exercise of the Underwriters’ over-allotment option (the “Offering”), with a syndicate of underwriters, led by Canaccord Genuity Corp., including Beacon Securities Limited, Cormark Securities Inc., Eight Capital, GMP Securities L.P., and PI Financial Corp., for gross proceeds of approximately $40.25 million.
Supreme Commences Production in New Flowering Rooms
TORONTO, Ontario, Nov. 7, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada.
This is Why Uruguay’s Hemp Crop Is Slated to Triple
It was only three months ago that Uruguay gave the green light for pharmacies to sell recreational marijuana, but now it looks like the country’s budding hemp crop is going to expand as well.
Supreme Receives Approval for Increased Capacity at 7ACRES Hybrid Facility
TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) announced today that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company’s Hybrid facility.
Emerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018
VICTORIA, British Columbia, Oct. 19, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH; OTCQX: EMHTF), through Emerald Health Botanicals Inc. (“Emerald”), its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has submitted license applications to Health Canada for approval of two new growing sites.
Supreme Pharmaceuticals Announces $30 Million Bought Deal Private Placement of Convertible Debenture Units
TORONTO, Ontario, Oct. 17, 2017 /Weed Wire/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $30,000,000 aggregate principal amount of convertible debenture units (the “Convertible Debenture Units”) at a price of $1,000 per Convertible Debenture Unit.
Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
This Is Why the North American Marijuana Index Increased 6% in September
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 6% in September on strong Canadian momentum.
Supreme to Quadruple Capacity at 7ACRES Hybrid Facility
TORONTO, Ontario, Oct. 4, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that 7ACRES has completed construction of three additional 10,000 sq. ft. flowering rooms at its Hybrid Facility, and applied to Health Canada for licensing.
Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation
PARIS, Ontario, Oct. 3, 2017 /Weed Wire/ — Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto.
Supreme Crosses Important Revenue Milestone
TORONTO, Ontario, Oct. 3, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that 7ACRES’ first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017.
Supreme Engages Leading Financial Communications Firm Bayfield Strategy
TORONTO, Ontario, Sept. 28, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that it has retained Bayfield Strategy, Inc. (“Bayfield”) to provide comprehensive Investor and Public Relations.
Supreme Strengthens Leadership Team to Prepare for Next Stage of Growth
TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce exciting changes and additions to our senior leadership team as the Company prepares for growth.
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
VICTORIA, British Columbia, Sept. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH; OCTQX: EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (Supreme) (TSXV: FIRE) subsidiary, 7ACRES.
Supreme Completes Sale with Emerald Health Botanicals Inc.
TORONTO, Ontario, Sept. 20, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc.
Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products
VICTORIA, British Columbia, Sept. 18, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (Therapeutics) (TSXV: EMH; OCTQX: EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product.
Two Public Companies to Supply New Brunswick Recreational Marijuana
On Sept. 15, 2017, the Canadian province of New Brunswick announced during a news conference that Organigram (TSXV:OGI) and Canopy Growth (TSX: WEED), both already licensed producers in Canada’s medical marijuana program, will distribute recreational marijuana to retail stores established by a newly created provincial crown corporation.
Canada Hit With Mandatory Cannabis Testing for Unauthorized Pesticides
Canada’s licensed producers will have to expand their testing checklists. On May 5, 2017, Health Canada announced that mandatory cannabis testing now includes testing for unauthorized pesticides.
Cronos Group Responds to Health Canada Testing
TORONTO, Ontario, May 5, 2017 /Weed Wire/ – Cronos Group Inc.’s (TSXV:MJN) wholly owned licensed producer, the Peace Naturals Project Inc. (“Peace”), was notified on May 4, 2017 by Health Canada that upon testing a random cannabis leaf sample, trace levels of Piperonyl Butoxide (PBO) were discovered at 0.78 parts per million (ppm). PBO is an organic compound known as a synergist.
Marijuana Index Fell 9% in April as US and Canadian Stocks Sell Off
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 9% in April due primarily to heavy losses in the United States.
Emerald Launches Market Leading CBD Oil and Supports Proposed Cannabis Legislation
VICTORIA, British Columbia, April 17, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) today announced the launch of its CBD-25< and CBD-50 medical cannabis oils containing 25mg and 50mg of CBD per ml.
Legalization Anticipation: Canadian Cannabis Stocks Gain 12.3% on Monday
While the Canadian Marijuana Index dipped slightly in March due to federal uncertainties, the Canadian public markets have bounced back today on the news of recreational marijuana legislation being introduced in Canada’s House of Commons this Thursday, April 13, 2017.
Marijuana Index Drops 2% as Canadian Stocks Dip With Federal Uncertainty
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 2% in March as losses in Canada overtook modest gains in the U.S.
Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO
VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.
Aurora Cannabis Appoints Neil Belot Chief Global Business Development Officer
VANCOUVER, British Columbia, March 21, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that Neil Belot has been promoted to Chief Global Business Development Officer.
Aurora to Acquire Peloton Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 6, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”).
Aurora Cannabis Expands E-commerce Strategy With Launch of Second Generation Mobile App
VANCOUVER, British Columbia, March 1, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company.
ICC Enters Into MOU and Presale Agreement With Emblem Corp. Setting in Motion a Framework for the Importation pf CBD Into Canada
VANCOUVER, British Columbia, Feb. 27, 2017 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) is pleased to announce that it has entered into a memorandum of understanding and presale agreement (the “MOU and Presale Agreement”) with Emblem Corp. (TSXV: EMC; OTCQB: EMMBF), who through a wholly-owned subsidiary, is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations overseen by Health Canada.
Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration Arrangements
VANCOUVER, British Columbia, Feb. 13, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies (“Radient”) (TSXV: RTI) are pleased to provide an update on their previously announced collaboration arrangements.
Canada to Start Random Testing of MMJ by Licensed Producers
On Feb. 7, 2017, Health Canada announced that it is going to start random testing of medical marijuana produced by all of the country’s licensed producers in an attempt to ensure patients aren’t being exposed to contaminated products.
Aurora Receives Health Canada License to Sell Cannabis Oils
VANCOUVER, British Columbia, Jan. 23, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils.
Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales
VANCOUVER, British Columbia, Jan. 16, 2017 /Weed Wire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
International Cannabis Corporation Announces Incorporation of Additional Land to Increase Production Capacity
VANCOUVER, British Columbia, Dec. 20, 2016 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) has entered into an agreement to lease approximately 9 hectares of additional land adjacent to the Company’s existing property used for the production of cannabinoid extracts and by-products for medicinal use and industrial hemp.
Canopy Growth Enters Into Agreement to Acquire Mettrum
SMITH FALLS, Ontario, Dec. 1, 2016 /Weed Wire/ — Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or the “Company”) and Mettrum Health Corp. (“Mettrum”) (TSXV: MT) are pleased to announce that they have entered into a definitive arrangement agreement.